ATWOOD BRIAN G has filed 27 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 1612099 shares of CERO THERAPEUTICS HOLDINGS, INC. ($CERO) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Stock Option (Right to Buy) | 1612099 | $0.00 | 1,612,099.0000 | 1,264,884 | 9999.99% | 100.00% |
| May 30, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Stock Option (Right to Buy) | 122549 | $0.00 | 122,549.0000 | 3,427,616 | 9999.99% | 3.58% |
| March 31, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | M | Pre-Funded Warrant | 294460 | $0.00 | 215,740.0000 | 579,432 | 0.00% | 50.82% |
| March 31, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | M | Common Stock | 294460 | $0.00 | 491,784.0000 | 579,432 | 149.23% | 50.82% |
| March 4, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Stock Option (Right to Buy) | 14936 | $0.00 | 14,936.0000 | 579,432 | 9999.99% | 2.58% |
| Feb. 24, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Stock Option (Right to Buy) | 254000 | $0.00 | 508,000.0000 | 579,432 | 100.00% | 43.84% |
| Feb. 7, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Pre-Funded Warrant | 204080 | $0.00 | 510,200.0000 | 579,432 | 66.67% | 35.22% |
| Feb. 7, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Warrant to Purchase Shares of Common Stock | 204080 | $1.96 | 510,200.0000 | 579,432 | 66.67% | 35.22% |
| Feb. 7, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Warrant to Purchase Shares of Common Stock | 306120 | $1.96 | 510,200.0000 | 579,432 | 150.00% | 52.83% |
| Feb. 7, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Pre-Funded Warrant | 306120 | $0.00 | 510,200.0000 | 579,432 | 150.00% | 52.83% |
| Dec. 2, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | A | Stock Option (Right to Buy) | 254000 | $0.00 | 254,000.0000 | 24,838 | 9999.99% | 100.00% |
| Sept. 30, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | D | Stock Option (Right to Buy) | 1317956 | $0.00 | 0.0000 | 8,099 | 100.00% | 100.00% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | M | Common Stock | 19358578 | $0.00 | 19,732,313.0000 | 8,099 | 5179.76% | 100.00% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | M | Series A Convertible Preferred Stock | 1002 | $1000.00 | 0.0000 | 8,099 | 100.00% | 12.37% |
| Sept. 30, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Director | D | Stock Option (Right to Buy) | 13857 | $0.00 | 0.0000 | 8,099 | 100.00% | 100.00% |
| March 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | A | Stock Option (Right to Buy) | 1317956 | $0.00 | 1,317,956.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | A | Series A Convertible Preferred Stock | 1002 | $1000.00 | 1,002.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 100527 | $0.00 | 100,527.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 148208 | $0.00 | 248,735.0000 | 292 | 147.43% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | A | Stock Option (Right to Buy) | 13857 | $0.00 | 13,857.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 148208 | $0.00 | 248,735.0000 | 292 | 147.43% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 100527 | $0.00 | 100,527.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | A | Series A Convertible Preferred Stock | 1002 | $1000.00 | 1,002.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 125000 | $0.00 | 373,735.0000 | 292 | 50.25% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 100527 | $0.00 | 225,527.0000 | 292 | 80.42% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | J | Common Stock | 148208 | $0.00 | 373,735.0000 | 292 | 65.72% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | ATWOOD BRIAN G | Chief Executive Officer | A | Series A Convertible Preferred Stock | 1002 | $1000.00 | 1,002.0000 | 292 | 9999.99% | 100.00% |